NexGel, STADA partner to launch Histasolv in North America

NEXGEL announced the first product to be distributed under its recently formed partnership with STADA Arzneimittel, STADA, a European leader in consumer health. Histasolv, sold as DAOSIN in Europe, is Europe’s number one selling Diamine Oxidase enzyme supplement generating well over $10 million in annualized revenue to treat histamine food intolerance, which can cause migraines and headaches, gut issues, and skin conditions. Headquartered in Germany, STADA is one of the fastest growing top ten companies in consumer healthcare and the fourth largest manufacturer in this segment in Europe.